These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10838574)

  • 1. Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides--players in the predicament of cystic fibrosis patients.
    Pier GB
    Trends Microbiol; 2000 Jun; 8(6):247-50; discussion 250-1. PubMed ID: 10838574
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
    Ernst RK; Yi EC; Guo L; Lim KB; Burns JL; Hackett M; Miller SI
    Science; 1999 Nov; 286(5444):1561-5. PubMed ID: 10567263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.
    Høiby N; Krogh Johansen H; Moser C; Song Z; Ciofu O; Kharazmi A
    Microbes Infect; 2001 Jan; 3(1):23-35. PubMed ID: 11226851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas survival strategies in cystic fibrosis.
    LeClerc JE; Cebula TA
    Science; 2000 Jul; 289(5478):391-2. PubMed ID: 10939947
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.
    Lo Sciuto A; Imperi F
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
    Pitt TL
    J R Soc Med; 1986; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
    [No Abstract]   [Full Text] [Related]  

  • 12. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM; Chusid MJ
    Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.
    Son MS; Matthews WJ; Kang Y; Nguyen DT; Hoang TT
    Infect Immun; 2007 Nov; 75(11):5313-24. PubMed ID: 17724070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.
    Cappiello F; Di Grazia A; Segev-Zarko LA; Scali S; Ferrera L; Galietta L; Pini A; Shai Y; Di YP; Mangoni ML
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7252-7262. PubMed ID: 27671059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
    Buyck JM; Guénard S; Plésiat P; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Mar; 67(3):771-5. PubMed ID: 22218683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.